Skip Navigation

COVID-19 Update

Practice Location

Add a Location+

Language

Add a Language+
  • A
    B
    C
    D
    E
    F
    G
    H
    I
    J
    K
    L
    M
    N
    P
    R
    S
    T
    U
    V
    Y

Doctor's Gender

Profile Results for Bone Marrow Transplantation (Hematologic Malignancies)

Displaying 1 to 10 of 20
  1. 1
  2. 2

Results per page: 10 ·  20 

  • Richard John Jones, M.D.

    co-leads the Hematologic Malignancies and Bone Marrow Transplantation Research Program. In...

    Richard J. Jones, M.D., is a Professor of Oncology and Medicine, Director of the Bone Marrow Transplantation Program, and Co-Director of the Hematologic Malignancies Program at The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. Dr. Jones...
  • Javier Bolanos Meade, M.D.

    J. HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning...

    As a member of the Johns Hopkins Kimmel Cancer Center, my group's research is focused on finding novel therapies for the treatment of both acute and chronic graft versus host disease (GVHD). To that end, we are developing new strategies for prophylax...
  • Richard F Ambinder, M.D., Ph.D.

    leader of the Hematologic Malignancies and Bone Marrow Transplantation Program and leads...

    Richard F. Ambinder, M.D., Ph.D., currently serves as the James B. Murphy Professor of Oncology and the Director of the Division of Hematologic Malignancies at the Johns Hopkins Kimmel Cancer Center. He is program co-leader of the Hematologic Maligna...
  • Ephraim Joseph Fuchs, M.D.

    J. HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning...

  • Carol Ann Huff, M.D.

    J. HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning...

    Carol Ann Huff, M.D., is an Associate Professor of Oncology and Medicine at the Johns Hopkins University School of Medicine and Medical Director for the Johns Hopkins Kimmel Cancer Center. After completing a Bachelor of Science in Zoology at Duke Uni...
  • Leonido Luznik, M.D.

    Fuchs: HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning...

    1990-1991 House Officer, University of Zagreb School of Medicine, Zagreb, Croatia
  • Douglas Edward Gladstone, M.D.

    focus is on hematologic malignancies, bone marrow transplantation (BMT), and autoimmunity...

    Douglas Gladstone, M.D., is a hematologist and medical oncologist at the Johns Hopkins Kimmel Cancer Center, and an Associate Professor of Oncology and Medicine at the Johns Hopkins University School of Medicine. He received his medical degree in 199...
  • Allen Ray Sing Chen, M.D., M.H.S., Ph.D.

    Patients with Relapsed Hematologic Malignancies after Related HLA-Haploidentical Bone Marrow Transplantation. Biol Blood Marrow Transplant. 2014 Mar...

    Chen's primary area of research focuses on bone marrow transplantation (BMT), a highly complex and specialized aspect of pediatric oncology that, in recent years, has become an accepted form of therapy for an increasingly broad range of cancers. In a...
  • Mark James Levis, M.D., Ph.D.

    co-directs the Hematologic Malignancies and Bone Marrow Transplantation Program and directs...

    Mark J. Levis, M.D., Ph.D., professor of oncology, medicine and pharmacology in the Division of Hematologic Malignancies at the Johns Hopkins University School of Medicine, co-directs the Hematologic Malignancies and Bone Marrow Transplantation Progr...
  • Elias Thomas Zambidis, M.D., Ph.D.

    system, histiocytic disorders, hematologic malignancies, blood and bone marrow transplantation (BMT), and regenerative...

    Dr. Zambidis is Associate Professor of Oncology and Pediatrics at the Johns Hopkins University School of Medicine, and a member of the Johns Hopkins Kimmel Cancer Center. Dr. Zambidis’ clinical expertise is in the treatment of disorders of the ...
  1. 1
  2. 2
back to top button